Luteolytic effectiveness of Preloban® or Croniben® products in holstein heifers

Abstract

The objective was to evaluate the effect of intramuscular injection of two different commercial products of cloprostenol (Preloban® or Croniprest®) on luteal regression of Holstein heifers. On a random day of the estrous cycle, 36 heifers were synchronized with an estradiol-progestin-PG-estradiol treatment. Twelve days after withdrawal of progestin, heifers were randomly divided into 3 groups of 12 animals. Groups 1 and 2 received the equivalent of 150 µg of d-cloprostenol of Croniben® or Preloban® products, while group 3 received 2 ml of saline. Estrus was detected with the aid of the dispositive Estrotec® on the following five days, and heifers that expressed estrus were inseminated. Blood samples were collected daily during the periods of 0, 24, 48 and 72 hours after the injection of d-cloprostenol for measurement of plasma progesterone by radioimmunoassay. Pregnancy diagnosis was performed by ultrasonography 40 days after insemination. The interval between the manifestation of estrus and the Croniben® or Preloban® injection was 68.4 ± 4.4 and 63.3 ± 4.6 hours, respectively (P>0.05). The distribution of estrus occurred in the period of 36 to 108 hours. With the exception of two heifers with incomplete luteolysis, all animals treated with d-cloprostenol showed complete luteolysis. The conception rate was 50.0% and 54.5% for Preloban® and Croniben® treatments, respectively (P > 0.05). We conclude that Preloban® and Croniben® products have similar effectiveness to induce luteolysis and and to synchronize the estrus of Holstein heifers. Thus, producer may choose any one of them without risk of compromising reproductive performance.

Keywords

• bovinos
• cloprostenol
• luteólise
• sincronização do cio